This was an 8-week randomized controlled trial (RCT), which aimed to examine the impacts of SCIT on improvements in psychosocial function, depressive symptoms, and serum BDNF/GDNF levels in FEDN MDD patients. Here, BDNF is linked to major depressive disorder.